Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting2
Terminated1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT07180901Not ApplicableRecruiting
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Head &Amp;Amp; Neck Squamous Cell CarcinomaLarynx Squamous Cell CarcinomaOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
PrincipalinvestigatorStart date: 2025-08-21
NCT04405401Phase 2Terminated
Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer
Lung Cancer Metastatic
StudychairStart date: 2021-01-05
NCT04178174Phase 3Recruiting
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Head and Neck CancerHuman Papilloma VirusOropharynx Cancer
StudychairStart date: 2020-02-23

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Phuc-Felix Nguyen-Tan, MD

Centre hospitalier de l'Université de Montréal (CHUM)

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of Head and NeckHuman Papillomavirus VirusesCancer of Oropharnyx

Worked with same sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)Jewish General Hospital+2 more
Collaborated on 1 trial
Similarity Score34%

Khalil Sultanem, MD

Montreal Jewish General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of Head and NeckHuman Papillomavirus VirusesCancer of Oropharnyx

Worked with same sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)Jewish General Hospital+2 more
Collaborated on 1 trial
Similarity Score34%

David Palma, MD PhD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of Head and NeckHuman Papillomavirus VirusesCancer of Oropharnyx

Worked with same sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)Jewish General Hospital+2 more
Collaborated on 1 trial
Similarity Score34%

Jack Phan, MD PhD

M.D. Anderson Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of Head and NeckHuman Papillomavirus VirusesCancer of Oropharnyx

Worked with same sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)Jewish General Hospital+2 more
Collaborated on 1 trial
Similarity Score34%

Bertrand Routy, MD PhD

Centre hospitalier de l'Université de Montréal (CHUM)

Related
1 trials

Shared therapeutic areas:

Lung Cancer Metastatic

Worked with same sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)
Collaborated on 1 trial
Similarity Score14%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckCancer of OropharnyxHuman Papillomavirus Viruses
Similarity Score13%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Human Papillomavirus Viruses
Similarity Score4%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score4%

Xinghua Gao

First Hospital of China Medical University

Related
5 trials

Shared therapeutic areas:

Human Papillomavirus Viruses
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07180901Not ApplicablePrincipalInvestigator

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer

Head &Amp;Amp; Neck Squamous Cell CarcinomaLarynx Squamous Cell CarcinomaOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Recruiting
NCT04405401Phase 2StudyChair

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Lung Cancer Metastatic
Terminated
NCT04178174Phase 3StudyChair

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Head and Neck CancerHuman Papilloma VirusOropharynx Cancer
Recruiting

All 3 trials loaded